Premier Biomedical Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.22 |
Market Cap |
$130.21 K |
Shares Outstanding |
9.72 M |
Public Float |
4.52 M |
Address |
PO Box 25 Jackson Center Pennsylvania 16133 United States |
Employees | - |
Website | http://www.premierbiomedical.com |
Updated | 07/08/2019 |
Premier Biomedical, Inc. is a research-based company, which engages in the development and marketing of medications and procedures. It intends to discover and develop medical treatments for humans, specifically targeting the treatment of alzheimer's disease, fibromyalgia, multiple sclerosis, traumatic brain injury, amyotrophic lateral sclerosis, blood sepsis and viremia, and cancer. The company was founded by Mitchell S. |